Synovial sarcoma is a rare, aggressive cancer of the soft tissue that can be quite resistant to treatment.
Doctors at Fred Hutchinson Cancer Research Center have created a vaccine that’s shown some impressive results in a phase one trial, with few minor side effects.
In Healthy Living, Courtney Hunter explains how they’re now working on making the vaccine even more effective.
Fred Hutchinson Cancer Research Center doctors and therapy developer Immune Design are pushing forward with more improvements for the vaccine.
Immune Design just announced a randomized phase three trial that will include the vaccine, the booster and a drug that blocks an immune checkpoint.
The trial should open next year.
© 2023 - 910 Media Group